首页> 美国卫生研究院文献>Journal of Neuroinflammation >Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway
【2h】

Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway

机译:通过有丝分裂原激活的蛋白激酶激酶/细胞外信号调节激酶途径调节实验性蛛网膜下腔出血中促炎性介质脑血管表达的增强

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSubarachnoid hemorrhage (SAH) is associated with high morbidity and mortality. It is suggested that the associated inflammation is mediated through activation of the mitogen-activated protein kinase (MAPK) pathway which plays a crucial role in the pathogenesis of delayed cerebral ischemia after SAH. The aim of this study was first to investigate the timecourse of altered expression of proinflammatory cytokines and matrix metalloproteinase in the cerebral arteries walls following SAH. Secondly, we investigated whether administration of a specific mitogen-activated protein kinase kinase (MEK)1/2 inhibitor, U0126, given at 6 h after SAH prevents activation of the MEK/extracellular signal-regulated kinase 1/2 pathway and the upregulation of cerebrovascular inflammatory mediators and improves neurological function.
机译:背景蛛网膜下腔出血(SAH)与高发病率和高死亡率相关。提示相关的炎症是通过丝裂原活化蛋白激酶(MAPK)途径的激活来介导的,该途径在SAH后延迟性脑缺血的发病机理中起着至关重要的作用。这项研究的目的是首先调查SAH后脑动脉壁中促炎细胞因子和基质金属蛋白酶表达改变的时程。其次,我们研究了在SAH后6小时给予特定的促分裂原激活的蛋白激酶激酶(MEK)1/2抑制剂U0126是否能阻止MEK /细胞外信号调节激酶1/2通路的激活和MAPK的上调。脑血管炎性介质并改善神经功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号